Tara Schmitz

Tara Schmitz has a diverse work experience in various scientific and research roles. In 2015, they worked as a Bachelor student at the University of Aberdeen, where they tested novel P-glycoprotein inhibitors for potential cancer treatment. Tara also gained experience in techniques such as MTT viability assay, Lowry assay, and cell culture.

In 2016, Tara worked as a Student Assistant at the University of Ulm, focusing on the synthesis and application of programmable hydrogels in regenerative medicine. Tara synthesized a DNA-Protein hybrid hydrogel and explored the feasibility of amyloid fibrils for enhanced cell attachment.

During the same year, they also completed a Student Internship at Ulm University, examining caveolae in lung cells under mechanical stress. Tara utilized fluorescently tagged proteins to visualize membrane-bound caveolin & cavin and evaluated protein detachment through microscopic analysis.

In 2017, Tara joined Nuvisan Group as an Intern, where they gained practical experience in a laboratory setting.

From 2018 to 2018, they worked as a Master-Student at the Max-Planck Institute of Colloids and Interfaces. Their thesis project focused on bacterial proteins involved in nanoparticle synthesis. Through their work, they identified two novel proteins potentially involved in magnetite nanoparticle biomineralization.

Since 2019, Tara has been working as a PHD Candidate at the Eindhoven University of Technology, contributing to scientific research and exploration in their field.

In 2023, Tara is set to join NC Biomatrix B.V. as a Senior Scientific Consultant, where they will likely utilize their extensive knowledge and experience in the scientific and research field.

Tara Schmitz's education history began in 2012 when they enrolled at Bonn-Rhein-Sieg University of Applied Sciences. Tara completed their Bachelor of Science (B.Sc.) in Applied Biology in 2015. Following their bachelor's degree, Tara pursued further education and attended Ulm University from 2015 to 2018, where they obtained their Master of Science (M.Sc.) in Molecular Medicine.

In 2019, Tara Schmitz began their doctoral studies at Eindhoven University of Technology. Tara is currently pursuing their Doctor of Philosophy (PhD) in Biomedical/Medical Engineering, with an expected completion date in 2023.

In addition to their academic qualifications, Tara Schmitz has also obtained certifications outside of their formal education. In December 2022, they completed a certification in Regenerative Medical Device Development from Holland Innovative. In January 2021, Tara acquired a certification in Visualize Data with Python from Codecademy.